Your Health, We Care
Cabergoline is an ergot derivative indicated for the treatment of hyperprolactinemic disorders in adults, whether idiopathic or caused by pituitary adenomas.
Usage Limitation: Avoid using cabergoline to suppress or terminate physiological lactation after childbirth, due to the risk of serious adverse reactions.
FDA，2025.04
